| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.6 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |